THERAKOS

Summary

THERAKOS Photopheresis is an extracorporeal photopheresis treatment approved by the US Food and Drug Administration.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 873 M

Avg. Deal Size£ 873 M

Market Context